Literature DB >> 26561939

Relationship of the serotonin transporter gene promoter polymorphism (5-HTTLPR) genotype and serotonin transporter binding to neural processing of negative emotional stimuli.

Noam Schneck1, Jeffrey M Miller2, Christine Delorenzo3, Toshiaki Kikuchi4, M Elizabeth Sublette2, Maria A Oquendo2, J John Mann2, Ramin V Parsey5.   

Abstract

BACKGROUND: The lower-expressing (S') alleles of the serotonin transporter (5-HTT) gene promoter polymorphism (5-HTTLPR) are linked to mood and anxiety related psychopathology. However, the specific neural mechanism through which these alleles may influence emotional and cognitive processing remains unknown. We examined the relationship between both 5-HTTLPR genotype and in vivo 5-HTT binding quantified via PET with amygdala reactivity to emotionally negative stimuli. We hypothesized that 5-HTT binding in both raphe nuclei (RN) and amygdala would be inversely correlated with amygdala reactivity, and that number of S' alleles would correlate positively with amygdala reactivity.
METHODS: In medication-free patients with current major depressive disorder (MDD; N=21), we determined 5-HTTLPR genotype, employed functional magnetic resonance imaging (fMRI) to examine amygdala responses to negative emotional stimuli, and used positron emission tomography with [(11)C]DASB to examine 5-HTT binding.
RESULTS: [(11)C]DASB binding in RN and amygdala was inversely correlated with amygdala response to negative stimuli. 5-HTTLPR S' alleles were not associated with amygdala response to negative emotional stimuli. LIMITATIONS: Primary limitations are small sample size and lack of control group.
CONCLUSIONS: Consistent with findings in healthy volunteers, 5-HTT binding is associated with amygdala reactivity to emotional stimuli in MDD. 5-HTT binding may be a stronger predictor of emotional processing in MDD as compared with 5-HTTLPR genotype.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Biological Markers; Brain Imaging; Depression; Functional MRI; Genetics

Mesh:

Substances:

Year:  2015        PMID: 26561939      PMCID: PMC5021308          DOI: 10.1016/j.jad.2015.10.047

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  52 in total

1.  Pharmacokinetic modeling and [¹²³]5-IA-85380 single photon emission computed tomography imaging in baboons: optimization of dosing regimen for ABT-089.

Authors:  Chih-Liang Chin; Robert A Carr; Daniel A Llano; Olivier Barret; Hongyu Xu; Jeffrey Batis; Andrei O Koren; John P Seibyl; Kennan C Marsh; Gilles Tamagnan; Michael W Decker; Mark Day; Gerard B Fox
Journal:  J Pharmacol Exp Ther       Date:  2010-12-20       Impact factor: 4.030

2.  Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity.

Authors:  P M Fisher; C C Meltzer; S K Ziolko; J C Price; E L Moses-Kolko; S L Berga; A R Hariri
Journal:  Nat Neurosci       Date:  2006-10-01       Impact factor: 24.884

Review 3.  Consensus nomenclature for in vivo imaging of reversibly binding radioligands.

Authors:  Robert B Innis; Vincent J Cunningham; Jacques Delforge; Masahiro Fujita; Albert Gjedde; Roger N Gunn; James Holden; Sylvain Houle; Sung-Cheng Huang; Masanori Ichise; Hidehiro Iida; Hiroshi Ito; Yuichi Kimura; Robert A Koeppe; Gitte M Knudsen; Juhani Knuuti; Adriaan A Lammertsma; Marc Laruelle; Jean Logan; Ralph Paul Maguire; Mark A Mintun; Evan D Morris; Ramin Parsey; Julie C Price; Mark Slifstein; Vesna Sossi; Tetsuya Suhara; John R Votaw; Dean F Wong; Richard E Carson
Journal:  J Cereb Blood Flow Metab       Date:  2007-05-09       Impact factor: 6.200

4.  Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder.

Authors:  Xian-Zhang Hu; Robert H Lipsky; Guanshan Zhu; Longina A Akhtar; Julie Taubman; Benjamin D Greenberg; Ke Xu; Paul D Arnold; Margaret A Richter; James L Kennedy; Dennis L Murphy; David Goldman
Journal:  Am J Hum Genet       Date:  2006-03-28       Impact factor: 11.025

5.  An expanded evaluation of the relationship of four alleles to the level of response to alcohol and the alcoholism risk.

Authors:  Xianzhang Hu; Gabor Oroszi; Jeffrey Chun; Tom L Smith; David Goldman; Marc A Schuckit
Journal:  Alcohol Clin Exp Res       Date:  2005-01       Impact factor: 3.455

6.  Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.

Authors:  Avshalom Caspi; Karen Sugden; Terrie E Moffitt; Alan Taylor; Ian W Craig; HonaLee Harrington; Joseph McClay; Jonathan Mill; Judy Martin; Antony Braithwaite; Richie Poulton
Journal:  Science       Date:  2003-07-18       Impact factor: 47.728

7.  Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography.

Authors:  Maria A Oquendo; Ramin S Hastings; Yung-Yu Huang; Norman Simpson; R Todd Ogden; Xian-Zhang Hu; David Goldman; Victoria Arango; Ronald L Van Heertum; J John Mann; Ramin V Parsey
Journal:  Arch Gen Psychiatry       Date:  2007-02

8.  Serotonin transporter genetic variation and the response of the human amygdala.

Authors:  Ahmad R Hariri; Venkata S Mattay; Alessandro Tessitore; Bhaskar Kolachana; Francesco Fera; David Goldman; Michael F Egan; Daniel R Weinberger
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

9.  The serotonin transporter gene polymorphism and the effect of baseline on amygdala response to emotional faces.

Authors:  Elisabeth A H von dem Hagen; Luca Passamonti; Sarah Nutland; Jennifer Sambrook; Andrew J Calder
Journal:  Neuropsychologia       Date:  2010-12-15       Impact factor: 3.139

10.  Modulation of amygdala response and connectivity in depression by serotonin transporter polymorphism and diagnosis.

Authors:  Sergi G Costafreda; Peter McCann; Pascal Saker; James H Cole; Sarah Cohen-Woods; Anne E Farmer; Katherine J Aitchison; Peter McGuffin; Cynthia H Y Fu
Journal:  J Affect Disord       Date:  2013-05-02       Impact factor: 4.839

View more
  5 in total

Review 1.  Type A monoamine oxidase and serotonin are coordinately involved in depressive disorders: from neurotransmitter imbalance to impaired neurogenesis.

Authors:  Makoto Naoi; Wakako Maruyama; Masayo Shamoto-Nagai
Journal:  J Neural Transm (Vienna)       Date:  2017-03-14       Impact factor: 3.575

2.  Decreased Pretreatment Amygdalae Serotonin Transporter Binding in Unipolar Depression Remitters: A Prospective PET Study.

Authors:  Mala R Ananth; Christine DeLorenzo; Jie Yang; J John Mann; Ramin V Parsey
Journal:  J Nucl Med       Date:  2017-09-21       Impact factor: 10.057

3.  Brain serotonin transporter binding, plasma arachidonic acid and depression severity: A positron emission tomography study of major depression.

Authors:  Manesh Gopaldas; Francesca Zanderigo; Serena Zhan; R Todd Ogden; Jeffrey M Miller; Harry Rubin-Falcone; Thomas B Cooper; Maria A Oquendo; Gregory Sullivan; J John Mann; M Elizabeth Sublette
Journal:  J Affect Disord       Date:  2019-07-05       Impact factor: 4.839

4.  The association of 5HT2A and 5HTTLPR polymorphisms with Alzheimer's disease susceptibility: a meta-analysis with 6945 subjects.

Authors:  Liang Tang; Jianming Li; Huaiqing Luo; Meihua Bao; Ju Xiang; Yiwei Chen; Yan Wang
Journal:  Oncotarget       Date:  2017-12-22

Review 5.  5HTTLPR Genetic Variant and Major Depressive Disorder: A Review.

Authors:  Caroline Fratelli; Jhon Siqueira; Calliandra Silva; Eduardo Ferreira; Izabel Silva
Journal:  Genes (Basel)       Date:  2020-10-26       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.